Big pharma still makes billions after patents lapse
Big pharma still makes billions after patents lapse
FT News in Focus · Financial Times
August 26, 201611m 1s
Audio is streamed directly from the publisher (sphinx.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Doctors in the US are wasting hundreds of millions of dollars a year prescribing expensive branded medicines even when cheaper generic alternatives are available, according to an FT analysis. David Crow and Sujeet Indap discuss the findings.
Hosted on Acast. See acast.com/privacy for more information.